StockGlow

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)

Chengdu Easton Biopharmaceuticals Co., Ltd., engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally.

44.68+0.01%Healthcare
Compare 688513.SS with
StockGlow Score
7
Bearish
BearishBullish
1 year ago-26.1%

The outlook

Chengdu Easton Biopharmaceuticals Co., Ltd. currently reads as bearish based on below its 50- & 200-day averages, 11% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$7.89B
52-wk high
80.48
52-wk low
40.25
50-day avg
49.76
200-day avg
57.84
Trailing P/E
28.3

Similar stocks

688488.SSJiangsu Aidea Pharmaceutical Group Co., Ltd.$13.83+2.22%300653.SZYantai Zhenghai Biotechnology Co., Ltd.$14.28+2.00%688222.SSHitGen Inc.$27.61+4.98%688266.SSSuzhou Zelgen Biopharmaceuticals Co., Ltd.$122.10+4.00%603590.SSBeijing Konruns Pharmaceutical Co.,Ltd.$29.76+0.88%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy